Victory Capital Management Inc A Tyr Pharma Inc Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.55 - $4.58 $3,317 - $5,958	-1,301 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.17 - $7.06 $1,549 - $5,040	714 Added 121.64%	1,301 $4,000
Q4 2019 Feb 04, 2020	BUY	$3.03 - $4.83 $436 - $695	144 Added 32.51%	587 $3,000
Q3 2019 Nov 12, 2019	BUY	$2.8 - $5.46 $1,240 - $2,418	443 New	443 $2,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.